A new study may help doctors assess the long-term risk for major bleeding if anticoagulation for unprovoked venous thromboembolisms (VTE) is continued beyond 3-6 months. The meta-analysis of data from 27 studies with 17,202 patients was published in the Annals…
Read More
‘No Reason to Drop tPA’ in Stroke Thrombectomy: SWIFT DIRECT
A new study has failed to show noninferiority of direct thrombectomy compared to bridging therapy with thrombolysis before thrombectomy for patients with large-vessel occlusion ischemic stroke. However, outcomes were very good for both groups. The trial, SWIFT DIRECT, was presented…
Read More
What Happens When You Let Your Wife Review Five of Your Papers?
The pantheon of husband-wife teams in science includes Marie and Pierre Curie, Gerty and Carl Cori, even Ugur Sahin and Özlem Türeci, the founders of BioNTech, which collaborated with Pfizer on a Covid-19 vaccine. To that list we hesitatingly add…
Read More
‘Healthy’ Plant-Based Diet Linked to Reduced Stroke Risk
Maintaining a healthy plant-based diet is associated with a lower risk for both total stroke and ischemic stroke, results from a study of three large cohorts suggest. A plant-based diet was not associated with risk for hemorrhagic stroke, however, and…
Read More
New ASH Guidelines: VTE Prevention, Treatment in Cancer Patients
New guidelines from the American Society of Hematology “strongly recommend” using no thromboprophylaxis over using parenteral thromboprophylaxis in ambulatory patients receiving cancer chemotherapy who have low venous thromboembolism (VTE) risk, and using no thromboprophylaxis over oral thromboprophylaxis with vitamin K…
Read More